Prophylactic Tranexamic Acid in General Surgery: Significant Reduction in Major Bleeding Without Thromboembolic Risk
Highlight
A comprehensive meta-analysis of 6,976 patients confirms that prophylactic tranexamic acid (TXA) reduces the risk of major bleeding by 28% and the need for blood transfusions by 25% across general surgical procedures.
Crucially, the administration of TXA was not associated with a statistically significant increase in venous thromboembolism (VTE) or overall mortality, addressing a long-standing safety concern in non-cardiac surgery.
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.